Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |